Chemotherapy in newly diagnosed primary central nervous system lymphoma

Por Hashemi-Sadraei, Nooshin, Peereboom, David M.
Publicado em 2010

CTIM-03. PHASE II STUDY OF REGORAFENIB IN BEVACIZUMAB REFRACTORY RECURRENT GLIOBLASTOMA

Por Rauf, Yasmeen, Schilero, Cathy, Peereboom, David, Ahluwalia, Manmeet
Publicado no Neuro Oncol (2020)

CMET-03. PHASE 1 TRIAL OF OSIMERTINIB WITH STEREOTACTIC RADIOSURGERY IN EGFR MUTANT LUNG CANCER BRAIN METASTASIS

Por Thapa, Bicky, Chao, Samuel, Pennell, Nathan, Peereboom, David, Ahluwalia, Manmeet
Publicado no Neuro Oncol (2018)

BIOM-30. DECREASED B CELL AND ALTERED CD4+ T CELL SUBSET RATIO PREDICT FAVORABLE RESPONSE TO RUXOLINITIB IN HIGH-GRADE GLIOMAS

Por Rauf, Yasmeen, Jia, Xuefei, Lathia, Justin, Peereboom, David, Ahluwalia, Manmeet
Publicado no Neuro Oncol (2020)

SURG-10. CONVECTION ENHANCED DELIVERY OF TOPOTECAN AND GADOLINIUM FOR RECURRENT GBM VIA THE CLEVELAND MULTIPORT CATHETER: A FIRST IN HUMAN STUDY

Por Vogelbaum, Michael, Mohammadi, Alireza, Brewer, Cathy, Peereboom, David M, Ahluwalia, Manmeet
Publicado no Neuro Oncol (2017)

DR-05 TREATMENT AND PROGNOSIS AFTER BEVACIZUMAB FAILURE IN RECURRENT GLIOBLASTOMA: THE CLEVELAND CLINIC EXPERIENCE

Por Sakruti, Susmita, Vyshak, Alva, Griffith, Sandra, Stevens, Glen, Peereboom, David, Ahluwalia, Manmeet
Publicado em 2014

ATNT-23 TEMOZOLOMIDE FOR "HIGH RISK" LOW-GRADE GLIOMA: THE CLEVELAND CLINIC EXPERIENCE

Por Sarmey, Nehaw, Murphy, Erin, Leyrer, Charles, Stevens, Glen, Peereboom, David, Ahluwalia, Manmeet
Publicado no Neuro Oncol (2015)

COMP-17. LARGE-SCALE TRANSCRIPTOMIC CHARACTERIZATION OF PRIMARY AND RECURRENT GLIOBLASTOMA IDENTIFIES GENE EXPRESSION SIGNATURE OF TUMOR RESPONSE TO STANDARD THERAPY

Por Dhawan, Andrew, Lathia, Justin, Peereboom, David, Barnett, Gene, Yeaney, Gabrielle, Ahluwalia, Manmeet
Publicado no Neuro Oncol (2019)

Isolated secondary CNS relapse in a case of stage I diffuse large B-cell lymphoma

Por Najjar, Yana G, Mittal, Kriti, Faza, Nadeen N, Dushkin, Holly, Peereboom, David M
Publicado em 2014

Hyperosmolar and methotrexate therapy avoiding surgery in the acute presentation of primary central nervous system lymphoma

Por Lee, Bryan S., Juthani, Rupa G., Healy, Andrew T., Peereboom, David M., Recinos, Violette M.
Publicado em 2014

EPID-04 PREVALENCE OF MALIGNANT PRIMARY BRAIN TUMORS IN THE UNITED STATES COMPARED TO OTHER COMMON CANCERS, 2010

Por Zhang, Adah, Ostrom, Quinn, Kruchko, Carol, Rogers, Lisa, Peereboom, David, Barnholtz-Sloan, Jill
Publicado no Neuro Oncol (2015)

Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010

Por Zhang, Adah S., Ostrom, Quinn T., Kruchko, Carol, Rogers, Lisa, Peereboom, David M., Barnholtz-Sloan, Jill S.
Publicado no Neuro Oncol (2017)

ACTR-09. TARGETING MYELOID DERIVED SUPPRESSOR CELLS: PHASE 0/1 TRIAL OF LOW DOSE CAPECITABINE + BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA

Por Peereboom, David, Lathia, Justin, Alban, Tyler, Mohammadi, Alireza, Ahluwalia, Manmeet, Brewer, Cathy, Vogelbaum, Michael
Publicado no Neuro Oncol (2018)

RBTT-01. RANDOMIZED PHASE 2 OPEN LABEL STUDY OF NIVOLUMAB PLUS STANDARD DOSE BEVACIZUMAB VERSUS NIVOLUMAB PLUS LOW DOSE BEVACIZUMAB IN RECURRENT GLIOBLASTOMA

Por Ahluwalia, Manmeet, Peereboom, David, Schilero, Cathy, Forst, Deborah, Wong, Eric, Wen, Patrick, Reardon, David
Publicado no Neuro Oncol (2018)

CTIM-20. PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

Por Rauf, Yasmeen, Peereboom, David, Fallah, Jaleh, Schilero, Cathy, Lackner, Pamela, Stevens, Glen, Ahluwalia, Manmeet
Publicado no Neuro Oncol (2020)

CTIM-10. PHASE II STUDY OF PEMBROLIZUMAB PLUS SurVaxM FOR GLIOBLASTOMA AT FIRST RECURRENCE

Por Ahluwalia, Manmeet, Peereboom, David, Rauf, Yasmeen, Schilero, Cathy, Ciolfi, Marci, Ciesielski, Michael, Fenstermaker, Robert
Publicado no Neuro Oncol (2020)

ACTR-26. SAFETY AND EFFICACY OF BEVACIZUMAB PLUS TTFIELDS IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM): DATA FROM A PHASE II CLINICAL TRIAL

Por Fallah, Jaleh, Chaudhary, Rekha, Rogers, Lisa, (Auston) Wei, Wei, Brewer, Cathy, Peereboom, David, Ahluwalia, Manmeet
Publicado no Neuro Oncol (2019)

EPID-11 WHO GRADE 3 GLIOMAS: CLINICAL AND MOLECULAR PROGNOSTIC FACTORS

Por Chi, Ming, Sarmey, Nehaw, Gotterer, Lauren, Chen, Zhijian, Stevens, Glen, Peereboom, David, Elson, Paul, Ahluwalia, Manmeet
Publicado no Neuro Oncol (2015)

EPID-14 OUTCOMES IN ELDERLY PATIENTS WITH HIGH GRADE GLIOMAS

Por Gotterer, Lauren, Sarmey, Nehaw, Chi, Ming, Chen, Zhijian, Stevens, Glen, Peereboom, David, Elson, Paul, Ahluwalia, Manmeet
Publicado no Neuro Oncol (2015)

MPTH-04 LOMUSTINE AS SALVAGE THERAPY IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA

Por Chen, Zhijian, Chi, Ming, Sarmey, Nehaw, Gotterer, Lauren, Stevens, Glen, Peereboom, David, Elson, Paul, Ahluwalia, Manmeet
Publicado no Neuro Oncol (2015)